# Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.

> **NCT05625334** · PHASE1 · COMPLETED · sponsor: **Vectura, Inc.** · enrollment: 86 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ASA
- **DRUG:** non-enteric-coated chewable aspirin

## Key facts

- **NCT ID:** NCT05625334
- **Lead sponsor:** Vectura, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-14
- **Primary completion:** 2023-03-09
- **Final completion:** 2023-03-09
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2024-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625334, "Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05625334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*